Therapy News and Research

RSS

Can apps slay the medical bill dragon?

Rachael Norman needed to submit a pile of out-of-network medical bills to her insurance company for reimbursement. Short on time, she started searching for a company that could do that tedious work for her.

15 Nov 2017

EKF’s PCT LiquiColor assay receives FDA clearance and validation for use on Beckman AU analyzers

EKF, announces that its Stanbio Chemistry Procalcitonin LiquiColor assay has been FDA cleared with Beckman AU 480, 680 and 5800 clinical chemistry analyzers.

From EKF Diagnostics 15 Nov 2017

Changes in multiple different genes drive world's most deadly forms of lung cancer

A new UC San Francisco–led study challenges the dogma in oncology that most cancers are caused by one dominant "driver" mutation that can be treated in isolation with a single targeted drug. Instead, the new research finds one of the world's most deadly forms of lung cancer is driven by changes in multiple different genes, which appear to work together to drive cancer progression and to allow tumors to evade targeted therapy.

15 Nov 2017

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration has approved FASENRA (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

14 Nov 2017

Medicaid coverage for methadone could improve outcomes for pregnant women with OUD

Pregnant women with opioid use disorder (OUD) are more likely to receive evidence-based treatment with an "opioid agonist"- usually methadone- in states where those medications are covered by Medicaid, reports a study in the December issue of Medical Care, published by Wolters Kluwer.

14 Nov 2017

Researchers test whether LVAD surgery could reverse frailty in older adults with heart failure

Common practice, and recently published research, shows that the risk of complications with surgery increases in very old or frail adults including those with heart failure.

14 Nov 2017

FDA approves first digital pill with sensor - Abilify MyCite

The United States Food and Drugs Administration (FDA), for the first time has approved a digital pill system. The novel pill comes with an in-built sensor that transmits information to a remote location after a person has taken it. Experts believe this is a huge step towards digital medicine and opens new avenues for therapy and diagnostics.

14 Nov 2017

Study provides new insights into basis for responsiveness of testicular cancer to chemotherapy

Cornell researchers have taken a major step toward answering a key question in cancer research: Why is testicular cancer so responsive to chemotherapy, even after it metastasizes?

14 Nov 2017

High-speed video capillaroscopy system enables accurate measurement of red blood cell velocity

Scientists from ITMO University created a high-speed video capillaroscopy system that enables direct measurement of red blood cell velocity.

14 Nov 2017

Cognitive behavioral therapy also has long-lasting effect for children, adolescents with OCD

Some children and adolescents think that they will have an accident if they do not count all the lampposts on their way to school. Or cannot leave the house unless they have washed their hands precisely twenty-five times.

14 Nov 2017

Study highlights importance of reinforcing sexual risk-reduction messages for older women with HIV

A new study that compared HIV-positive women over 50 years of age with their younger HIV-infected cohorts found that while the older women were less likely to be sexually active and to report condomless sex with a male partner, those who were sexually active were not as likely to undergo screening for gonorrhea, chlamydia, or syphilis than their younger counterparts.

14 Nov 2017

Dresden researchers develop molecular smoke alert for key human cancer gene

If it burns in a house smoke detectors alert us hence protecting life. A molecular smoke alert has now been developed by Dresden researchers for the TP53 gene, the most important human cancer gene. The alert goes on if the TP53 gene is mutated in cells.

14 Nov 2017

Breakthrough discovery could radically change approach to treating Klebsiella infections

Researchers at Queen's University Belfast together with the University of Vienna have discovered that treatment for the antibiotic-resistant bacteria Klebsiella pneumoniae could lie within our bodies' natural defenses.

14 Nov 2017

Novel AR glasses help doctors to locate lymph nodes during surgery

Malignant tumors often form metastases that spread to other parts of the body via the lymphatic system. High surgical skills are required to identify the precise location of the affected lymph nodes, enabling them to be completely removed.

14 Nov 2017

Monoclonal antibody effectively blocks development of graft-versus-host disease, research shows

Newly published research provides preclinical proof-of-concept for the ability of PRO 140, a humanized anti-CCR5 monoclonal antibody under development by CytoDyn Inc., to effectively block the development of graft-versus-host disease (GvHD), a potentially lethal complication of bone marrow stem cell (BMSC) transplantation.

14 Nov 2017

Anti-parasite drug acts like tailored medicine against colon, prostate cancer

Medicine against parasites like Tapeworms and Giardia, contains a substance that kills Prostate- and colon cancer.

14 Nov 2017

Study details complementary and alternative medicine service offerings at military treatment facilities

A new study evaluating the use of complementary and alternative medicine (CAM) across the military health system shows that the large majority of military treatment facilities offer at least one type of CAM, and an estimated 76,000 military patients receive integrative health services each month.

14 Nov 2017

Analysis finds simple method to identify patients most likely to benefit from long-term canakinumab treatment

A new analysis seeks to answer the question of which patients are likely to gain the greatest cardiovascular benefit when treated with the anti-inflammatory agent canakinumab.

14 Nov 2017

PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease

Patients with peripheral artery disease (PAD) are at high risk of heart attack, stroke and cardiovascular death. In addition, PAD patients can suffer major adverse limb events, such as acute limb ischemia - the equivalent of a heart attack in the leg - that can lead to limb loss.

14 Nov 2017

Absence of VEGF-A in cancer-killing T cells accelerates tumor development

Contrary to what was previously believed, the immune system's cancer-killing T cells are more effective in a tumour's anoxic environment when they have access to growth factor VEGF-A.

13 Nov 2017

Therapy News and Research

Can apps slay the medical bill dragon?

EKF’s PCT LiquiColor assay receives FDA clearance and validation for use on Beckman AU analyzers

Changes in multiple different genes drive world's most deadly forms of lung cancer

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

Medicaid coverage for methadone could improve outcomes for pregnant women with OUD

Researchers test whether LVAD surgery could reverse frailty in older adults with heart failure

FDA approves first digital pill with sensor - Abilify MyCite

Study provides new insights into basis for responsiveness of testicular cancer to chemotherapy

High-speed video capillaroscopy system enables accurate measurement of red blood cell velocity

Cognitive behavioral therapy also has long-lasting effect for children, adolescents with OCD

Study highlights importance of reinforcing sexual risk-reduction messages for older women with HIV

Dresden researchers develop molecular smoke alert for key human cancer gene

Breakthrough discovery could radically change approach to treating Klebsiella infections

Novel AR glasses help doctors to locate lymph nodes during surgery

Monoclonal antibody effectively blocks development of graft-versus-host disease, research shows

Anti-parasite drug acts like tailored medicine against colon, prostate cancer

Study details complementary and alternative medicine service offerings at military treatment facilities

Analysis finds simple method to identify patients most likely to benefit from long-term canakinumab treatment

PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease

Absence of VEGF-A in cancer-killing T cells accelerates tumor development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News